Cargando…

Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway

Dihydroartemisinin (DHA) is a widely used antimalarial drug isolated from the plant Artemisia annua. Recent studies suggested that DHA has antitumor effects utilizing its reactive oxygen species (ROS) yielding mechanism. Here, we reported that DHA is inhibitory on lipopolysaccharide (LPS)-induced os...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dou, C, Ding, N, Xing, J, Zhao, C, Kang, F, Hou, T, Quan, H, Chen, Y, Dai, Q, Luo, F, Xu, J, Dong, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823966/ https://www.ncbi.nlm.nih.gov/pubmed/27031959 http://dx.doi.org/10.1038/cddis.2016.69

Ejemplares similares

Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption
por: Niu, Chenguang, et al.
Publicado: (2017)

Cilostazol Attenuates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis
por: Ke, Ke, et al.
Publicado: (2015)

Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling
por: Kwak, Sung Chul, et al.
Publicado: (2019)

Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo
por: Peng, Jiaxuan, et al.
Publicado: (2020)

Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation
por: Dou, Ce, et al.
Publicado: (2016)

The blocking of uPAR suppresses lipopolysaccharide‐induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathway
por: Kanno, Yosuke, et al.
Publicado: (2016)

Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL‐induced osteoclastogenesis
por: Qian, Zhi, et al.
Publicado: (2020)

Synthesis and Antitumor Activities of Novel Mitochondria-Targeted Dihydroartemisinin Ether Derivatives
por: Xu, Cangcang, et al.
Publicado: (2022)

Physalin D inhibits RANKL-induced osteoclastogenesis and bone loss via regulating calcium signaling
por: Ding, Ning, et al.
Publicado: (2020)

IL-12 Inhibits Lipopolysaccharide Stimulated Osteoclastogenesis in Mice
por: Yoshimatsu, Masako, et al.
Publicado: (2015)

Lipopolysaccharide (LPS)-Induced Autophagy Is Responsible for Enhanced Osteoclastogenesis
por: Sul, Ok-Joo, et al.
Publicado: (2017)

Dihydroartemisinin attenuates osteoarthritis by inhibiting abnormal bone remodeling and angiogenesis in subchondral bone
por: Ma, Long, et al.
Publicado: (2021)

Traditional Chinese decoction Si Zhi Wan attenuates ovariectomy (OVX)-induced bone loss by inhibiting osteoclastogenesis and promoting apoptosis of mature osteoclasts
por: He, Qingman, et al.
Publicado: (2022)

AMPKα1 negatively regulates osteoclastogenesis and mitigates pathological bone loss
por: Ribeiro, Mariana S.P., et al.
Publicado: (2023)

Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss
por: Hou, Weiduo, et al.
Publicado: (2022)

Dihydroartemisinin attenuates lipopolysaccharide-induced acute lung injury in mice by suppressing NF-κB signaling in an Nrf2-dependent manner
por: Huang, Xiao-Ting, et al.
Publicado: (2019)

Involvement of interleukin-23 induced by Porphyromonas endodontalis lipopolysaccharide in osteoclastogenesis
por: Ma, Nan, et al.
Publicado: (2017)

Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
por: Zhang, Peng, et al.
Publicado: (2022)

Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1
por: Hou, Huanhuan, et al.
Publicado: (2020)

Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
por: Xu, Qiang, et al.
Publicado: (2021)

Suppression of Inflammation, Osteoclastogenesis and Bone Loss by PZRAS Extract
por: Li, Liang, et al.
Publicado: (2020)

Dihydroartemisinin attenuates pulmonary inflammation and fibrosis in rats by suppressing JAK2/STAT3 signaling
por: You, Xiaolan, et al.
Publicado: (2022)

Betaine Attenuates Osteoarthritis by Inhibiting Osteoclastogenesis and Angiogenesis in Subchondral Bone
por: Yajun, Wang, et al.
Publicado: (2021)

Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast‐induced bone loss by modulating NF‐κB signalling pathway
por: Hu, Bin, et al.
Publicado: (2019)

Theaflavin-3, 3′-Digallate Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Ovariectomy-Induced Bone Loss in Mice
por: Ai, Zexin, et al.
Publicado: (2020)

Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway
por: Wu, Haobo, et al.
Publicado: (2018)

Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
por: Zhang, Yong, et al.
Publicado: (2015)

Bone Loss in Intestinal Inflammation Disease Yields to Osteoclastogenesis Inhibition
por: Strober, Warren
Publicado: (2022)

TMBIM6 deficiency leads to bone loss by accelerating osteoclastogenesis
por: Yi, Sun-Ju, et al.
Publicado: (2023)

Egg White Ovotransferrin Attenuates RANKL-Induced Osteoclastogenesis and Bone Resorption
por: Shang, Nan, et al.
Publicado: (2019)

Resistance to Dihydroartemisinin
por: Cojean, Sandrine, et al.
Publicado: (2006)

Resistance to Dihydroartemisinin
por: Legrand, Eric, et al.
Publicado: (2007)

Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015)

T cell and periosteum cooperation in osteoclastogenesis induced by lipopolysaccharide injection in transplanted mouse tibia
por: Kobayashi, Hiroki, et al.
Publicado: (2018)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
por: AlQranei, Mohammed S., et al.
Publicado: (2021)

Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway
por: Chen, Yueqi, et al.
Publicado: (2020)

Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II
por: Kollmann, Katrin, et al.
Publicado: (2013)

Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis
por: Kim, Woon-Ki, et al.
Publicado: (2012)

Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice
por: Goto, Tadashi, et al.
Publicado: (2014)

Dihydroartemisinin-induced mitochondrial mRNA degradation and apoptosis in keloid fibroblasts
por: Li, Qijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ib19iice19j5fh524jmgcnfg7